News | CQDM unveils Ï㽶ÊÓƵ Therapy Development and Production Network, led by McGill, IRCM, and University of Sherbrooke
On June 11, 2024 CQDM announced the creation of the Ï㽶ÊÓƵ Therapy Development and Production Network, which will offer Ï㽶ÊÓƵ therapy biomanufacturing services to academic and industrial researchers.
This initiative is led by the Ï㽶ÊÓƵ, IRCM, and Sherbrooke University, and it is one of the five key initiatives of the mobilizing project on Ï㽶ÊÓƵ therapies announced on April 30 by the Government of Quebec. The aim of this initiative is to strengthen the Ï㽶ÊÓƵ therapy ecosystem in Quebec and fast-track the province to become a world leader in this field.
°Õ³ó¾±²õÌýNetwork will be based on three complementary platforms at the partner institutions:
- Therapeutic messenger Ï㽶ÊÓƵ platform at Ï㽶ÊÓƵ’s Centre for Ï㽶ÊÓƵ Sciences
- Sherbrooke University’s RNomic Platform
- IRCM’s Sidney-Altman Ï㽶ÊÓƵ Therapeutic Hub
Information about McGill's Centre for Ï㽶ÊÓƵ Sciences new therapeutic messenger Ï㽶ÊÓƵ platform:Â
McGill will contribute to the Network with a new therapeutic messenger Ï㽶ÊÓƵ platform. This platform will cater to the requirements of ongoing activities and research being conducted by McGill's Centre for Ï㽶ÊÓƵ Sciences, D2R funded projects, as well as Network partner institutions and industries in the province. Messenger Ï㽶ÊÓƵ modalities are key to the main therapeutic approaches emerging in precision medicine. These include neo-antigenic vaccines against cancer, CART programming and self-amplifying Ï㽶ÊÓƵ. The platform will provide services in bioproduction and the formulation of LNP nanoparticles on a pre-clinical level of various messenger Ï㽶ÊÓƵ modalities, individually or collectively. Their quality control will be based on strict standardized criteria, as well as a functional base validation. Access to this platform will be possible at the beginning of 2026.
Congratulations to all the researchers involved!Â
For more details, read CQDM's  and this as part of this Network.